PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

Take a deep breath, page-27

  1. 1,646 Posts.
    lightbulb Created with Sketch. 174
    No, if you refer to a couple of posts back, I said
    if we don’t enter into a partnership until much
    later in P3 trial stages or even after RA, we
    will have a much better bargaining position
    with BP; but by all means if we can gain a
    really favourable agreement anytime between
    now and then, whether it is for MPS or OA,
    go for it.

    Unless there is an unexpected catalyst to boost
    the share price in the next 6-12 months, IMO,
    PAR are going to find it very difficult to CR or
    sign a lucrative agreement with BP. If share
    markets turn nasty, PAR management will be
    ”between a rock and a hard place.” This will
    put enormous pressure on them to water
    down terms with BP.




 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
19.0¢
Change
-0.010(5.00%)
Mkt cap ! $66.54M
Open High Low Value Volume
20.0¢ 21.0¢ 19.0¢ $203.4K 1.019M

Buyers (Bids)

No. Vol. Price($)
14 387930 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
20.5¢ 65468 2
View Market Depth
Last trade - 16.10pm 27/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.